1-benzenesulfonyl-1H-indole derivatives as inhibitors of CCR9 activity

Details for Australian Patent Application No. 2008212887 (hide)

Owner Novartis AG

Inventors Lehr, Philipp; Winiski, Anthony

Agent Davies Collison Cave

Pub. Number AU-A-2008212887

PCT Pub. Number WO2008/095908

Priority 07101784.2 06.02.07 EP

Filing date 4 February 2008

Wipo publication date 14 August 2008

International Classifications

C07D 209/42 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/404 (2006.01)

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

Event Publications

23 July 2009 PCT application entered the National Phase

  PCT publication WO2008/095908 Priority application(s): WO2008/095908

19 July 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008212891-Game Apparatus And Computer Program

2008212870-Method for obtaining a valuable product, particularly starch, from grain flour